PKO Investment Management Joint-Stock’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Sell
14,900
-5,000
-25% -$333K 0.07% 175
2026
Q1
$1.25M Sell
19,900
-34,100
-63% -$2.37M 0.11% 143
2025
Q4
$3.58M Hold
54,000
0.29% 76
2025
Q3
$3.63M Buy
54,000
+17,000
+46% +$1.35M 0.31% 70
2025
Q2
$3.23M Sell
37,000
-54,000
-59% -$4.23M 0.35% 69
2025
Q1
$6.21M Buy
91,000
+43,000
+90% +$3.51M 0.7% 35
2024
Q4
$3.73M Sell
48,000
-47,000
-49% -$3.48M 0.46% 44
2024
Q3
$6.37M Buy
95,000
+57,000
+150% +$4.68M 0.79% 20
2024
Q2
$4.31M Buy
38,000
+35,500
+1,420% +$4.49M 0.53% 31
2024
Q1
$348K Sell
2,500
-1,500
-38% -$189K 0.04% 150
2023
Q4
$496K Sell
4,000
-8,000
-67% -$817K 0.06% 132
2023
Q3
$1.12M Buy
12,000
+10,000
+500% +$1.13M 0.15% 89
2023
Q2
$257K Sell
2,000
-2,000
-50% -$242K 0.03% 141
2023
Q1
$465K Buy
4,000
+2,000
+100% +$224K 0.06% 129
2022
Q4
$226K Sell
2,000
-2,000
-50% -$220K 0.03% 132
2022
Q3
$322K Sell
4,000
-4,000
-50% -$339K 0.05% 126
2022
Q2
$596K Buy
8,000
+3,200
+67% +$292K 0.09% 107
2022
Q1
$614K Buy
+4,800
New +$525K 0.07% 104

Other funds holding DXCM

PKO Investment Management Joint-Stock's DXCM Position: Q2 2026 in Review

PKO Investment Management Joint-Stock reduced its DexCom (DXCM) stake by 25% in Q2 2026, selling an estimated $333K and leaving 14,900 shares worth $1M. The position accounts for 0.07% of the portfolio, ranked #175.

PKO Investment Management Joint-Stock first reported a position in DXCM in Q1 2022 and has held it in 18 quarters since. The position peaked at $6.37M in Q3 2024. 307 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • PKO Investment Management Joint-Stock held 14,900 shares of DexCom worth $1M as of Q2 2026.
  • PKO Investment Management Joint-Stock sold 5,000 DexCom shares in Q2 2026, an estimated $333K.
  • DexCom made up 0.07% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #175 holding.
  • PKO Investment Management Joint-Stock first reported a position in DexCom in Q1 2022 and has held it in 18 quarters since.
  • PKO Investment Management Joint-Stock's DexCom position peaked at $6.37M in Q3 2024.
  • 307 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.